ClinicalTrials.Veeva

Menu

Microbial Markers for AGI

P

Peking University

Status

Unknown

Conditions

Acute Gastrointestinal Injury

Treatments

Other: none intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04957888
LM2020203

Details and patient eligibility

About

AGI is very common in ICU and sometimes will trigger the development of gut derived sepsis. Thus, to find out the biomarker in early stage is very important to improve the overall prognosis of critically ill patients. In this project we try to find out the microbial biomarker of AGI through multi-omic technology.

Enrollment

584 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: All those critically ill patients with anticipated ICU stay for more than 2 days Exclusion Criteria:Patients will be excluded if they have any of the following situations: patients who have not signed the informed consent; Unable to tolerate intra-abdominal pressure monitoring; pregnant woman; Patients after bladder surgery; Systemic diseases and recent use of related drugs; He had a history of infectious diseases, such as tuberculosis or PPD positive. History of hypertension and poor blood pressure control (SBP / DBP > = 140mmHg); Patients with severe mental illness; Long term use of traditional Chinese medicine, probiotics, gastric mucosal protective agents, proton pump inhibitors, chemotherapy or immunosuppressive drugs, etc. were not included if the drug was not stopped within one month before admission.

Trial design

584 participants in 2 patient groups

training group
Description:
the observational group to find out the potential biomarker
Treatment:
Other: none intervention
validation group
Description:
the validation group to validate the parameters used for early diagnosis
Treatment:
Other: none intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems